Pharma majors to see muted growth in FY24: ICRA
Growth will be supported by 8-10% expansion in domestic market and 6-8% growth in US market, the agency says
indian pharma companies
July 2023
April 2023
September 2022
November 2021
October 2021
Pharma cos' revenue to grow 6-8% in FY24: ICRA
Revenue growth will be driven by steady performance across key markets — the U.S. and India — and some recovery in growth in the European market.
Surprise! Despite Covid-19 sales, Indian pharma an underperformer
A majority of pharma stocks reported double digit negative returns, while the overall market (BSE Sensex) delivered a 9% plus return.
Competitors Within
Home-grown smaller players are giving biggies a run for their money in the US generics market.
Quality issues remain for Indian pharma companies: USFDA
The problems faced by FDA’s investigators in India are similar to those around the world, US Food and Drug Administration spokesperson Jeremy Kahn tells Fortune India.
